CME Activity Information	Important dates for this Course
Accreditation/CME Credit CME Instructions For Credit Disclosure Privacy Statement Hardware/Software Requirements	Released: March 1, 2007 Expired: March 1, 2008

LEARNING OBJECTIVES: Recent Progress in the Management of Advanced Renal Cell Carcinoma

After completing this activity, the learner should be able to:

•  Understand current treatment recommendations for advanced renal cell carcinoma (RCC).
•  Review the roles of cytokine therapies and antiangiogenesis therapies for metastatic RCC.
•  Discuss some promising investigational approaches to targeted therapy of advanced RCC.

The ACS designates this educational activity for a maximum of one category 1 credit toward the AMA Physician’s Recognition Award.

This activity is approved for 1 AAFP Prescribed credit. Credit may be claimed for 1 year from the date of this issue. The physician should claim only those hours of credit that he or she actually spent in the educational activity. The online quiz must be completed by March 1, 2008.

Each question has ONE best answer.